Back to Results
First PageMeta Content
Business / Financial ratios / Fundamental analysis / Cash flow / Valuation / Earnings before interest / taxes / depreciation and amortization / Net profit / EV/EBITDA / Profit / Generally Accepted Accounting Principles / Finance / Accountancy


Microsoft Word - Aurobindo-3QFY2013
Add to Reading List

Document Date: 2013-02-12 01:45:15

Open Document

File Size: 276,48 KB

Share Result on Facebook

Company

Pfizer / Aurobindo Pharma / Interest Adj. Net / Lupin Alembic Pharma / Bloomberg / Cipla / Tax Adj. Net / AstraZeneca / Aurobindo Pharmaceuticals Ltd / Adj. net / Reuters / /

Continent

Europe / /

Country

United States / South Africa / /

Currency

USD / /

Event

Business Partnership / /

IndustryTerm

generic pharmaceuticals / active pharmaceutical ingredient / abbreviated new drug applications / manufacturing facilities / active pharmaceutical ingredients / /

Organization

World Health Organization / MHRA / /

/

Position

formidable formulations player / /

Product

Ipca / /

Technology

API / CMP / /

SocialTag